Sustained virological response to ombitasvir/paritaprevir/ritonavir and dasabuvir treatment for hepatitis C: Real‐world data from a large healthcare provider
C. Weil; D. Mehta; G. Koren; B. Pinsky; J. C. Samp; G. Chodick; V. Shalev
Author Information: Epidemiology and Database Research
|Checking for direct PDF access through Ovid|
Abstract unavailable for this article.